4 completed, 1 terminated. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow TGN-1412: new trials by email Literature Review of TGN-1412 trials Research Report on TGN-1412
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms TAB08 - Solid Tumors | Phase 1 | Completed | Theramab LLC | 12 | 2017-02-08 | 2021-10-06 |
| TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment TAB08, Placebo - Psoriasis Vulgaris | Phase 1 / Phase 2 | Completed | Theramab LLC | 9 | 2016-04-01 | 2017-02-15 |
| TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment TAB08, Placebo - Lupus Erythematosus, Systemic | Phase 2 | Terminated | Theramab LLC | 60 | 2016-03-01 | 2018-05-23 |
| Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis TAB08 - Rheumatoid Arthritis | Phase 1 / Phase 2 | Completed | Theramab LLC | 18 | 2013-11-01 | 2017-02-28 |
| Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers TAB08 - Adult Healthy Volunteers | Phase 1 | Completed | Theramab LLC | 31 | 2011-11-01 | 2017-02-15 |
Arthritis, Rheumatoid (1) · Lupus Erythematosus, Systemic (1)
Theramab LLC (5)
Russia (5)
Daniil Nemenov, M.D. (2) · Daniil G Nemenov, M.D. (1) · Daniil G Nemenov, MD (1) · Olga B Ershova, Prof. (1)